Pavilion Capital
Pavilion Capital is providing growth equity to market leading companies.
Business Model:
Revenue: $2M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Pavilion Capital Information
Geographic Data
Address: 270 Lafayette St
City: New York
State: NY
Zip: 10012
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
7,304,025Website Global Rank
542Website Monthly Traffic
Twitter Followers
Description
Pavilion Capital Partners is a growth-oriented private equity investor. It provides capital and strategic support to companies in the United States and Asia. In particular, the focus is on industries experiencing high growth due to globalization, technology, or demographic trends. It actively works with company founders/management to assist in strategic initiatives, mergers and acquisitions, and eventual liquidity. The pavilion is partnered with family offices and private equity funds and is based in New York City.
Contact Phone:
+12126758289
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2021 | Hydrogenious Technologies | Venture Round | 0 |
| 9/2020 | waresix | Series B | 0 |
| 8/2022 | Zilliz | Series B | 60M |
| 4/2022 | RVAC Medicines | Series B | 140M |
| 8/2019 | CyCraft | Series B | 5.7M |
| 11/2022 | Vow | Series A | 0 |
| 5/2021 | Blind | Series C | 0 |
| 9/2022 | Asuene | Series B | 17.5M |
| 4/2022 | ENSEM Therapeutics | Series A | 67M |
| 9/2019 | Advance Intelligence Group | Series C | 80M |
| 11/2016 | Appier | Series B | 19.5M |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 8/2022 | Insilico Medicine | Series D | 35M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 5/2021 | Inari | Series D | 0 |
| 7/2020 | Sociolla | Series E | 58M |
| 3/2021 | Sicepat Express | Series B | 0 |
| 7/2021 | OY! | Series A | 0 |
| 11/2022 | JNPMEDI | Series A | 10.3M |
| 11/2019 | Cityneon | Private Equity Round | - |
| 4/2023 | Travelio | Series C | - |
| 11/2019 | Appier | Series D | 80M |
| 11/2020 | Zilliz | Series B | 43M |
| 4/2015 | TMON | Private Equity Round | 360M |
| 10/2021 | Accredify | Series A | 0 |
| 2/2020 | KAHR medical | Venture Round | 18M |
| 3/2021 | Duckbill | Venture Round | 0 |
| 2/2020 | GudangAda | Seed Round | 10.5M |
| 6/2021 | SUPER STUDIO | Venture Round | 1.6M |
| 6/2021 | KAHR medical | Venture Round | 0 |
| 5/2019 | Schrödinger | Series E | 25M |
| 1/2019 | Warung Pintar | Series A | 0 |
| 9/2014 | STAR 360 | Private Equity Round | - |
| 6/2016 | SORACOM | Series B | 28.6M |
| 6/2018 | Insilico Medicine | Series A | 6M |
| 12/2018 | 17LIVE | Venture Round | 25M |
| 10/2021 | Infinium | Venture Round | 0 |
| 8/2019 | Edmicro | Seed Round | - |
| 6/2021 | Standigm | Series D | 10M |
| 1/2020 | OY! | Seed Round | - |
| 3/2022 | Ark Edge Space | Series A | 5.2M |
| 3/2022 | Synspective | Series B | 96.6M |
| 12/2021 | UrBox | Series A | - |
| 4/2021 | Touchstone Partners | Series A | 25M |
| 5/2021 | NiKang Therapeutics | Series C | 200M |
| 3/2020 | Doctor Anywhere | Series B | 27M |
| 12/2022 | QuQo | Seed Round | 1M |
| 7/2021 | Atama plus | Series B | 0 |
| 10/2019 | Structo | Series D | - |
| 11/2021 | Linc&s;well | Series C | 69.5M |
| 11/2019 | Travelio | Series B | 0 |
| 8/2018 | Warung Pintar | Seed Round | 0 |
| 1/2019 | Fore Coffee | Series A | 9.5M |
| 11/2021 | HEPMIL | Series A | 0 |
| 12/2021 | ROKT | Series E | 325M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 12/2021 | Space BD | Venture Round | 9.2M |
| 4/2022 | Swatch On | Venture Round | 10M |
| 5/2022 | MOMA Therapeutics | Series B | 0 |
| 9/2021 | Allay Therapeutics | Series C | 60M |
| 12/2018 | Airobotics | Series D | 40.3M |
| 1/2020 | ReadCoor | Series B | 27M |
| 10/2022 | LevitasBio | Series C | 35M |
| 10/2019 | Nuvation Bio | Series A | 275M |
| 11/2021 | HotSpot Therapeutics | Series C | 0 |
| 12/2017 | Orchard Therapeutics | Series B | 0 |
| 7/2021 | Pivot Bio | Series D | 0 |
| 4/2020 | Pivot Bio | Series C | 0 |
| 3/2023 | Flare Therapeutics | Series B | 0 |
| 4/2021 | Studist | Venture Round | 17.1M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 6/2021 | SUPER STUDIO | Funding Round | 1.6M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 5/2022 | MOMA Therapeutics | Series B | 0 |
| 4/2022 | RVAC Medicines | Series B | 0 |
| 4/2022 | Swatch On | Venture Round | 0 |
| 4/2022 | ENSEM Therapeutics | Series A | 0 |
| 3/2022 | Synspective | Series B | 0 |
| 3/2022 | Ark Edge Space | Series A | 0 |
| 12/2021 | ROKT | Series E | 0 |
| 12/2021 | UrBox | Series A | - |
| 12/2021 | Space BD | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
